Chromosome-mediated alterations of the MYC gene in human cancer

Journal of Cellular and Molecular Medicine

Volumn 6, Issue 2, 2002, Pages 151-159

  Popescu, Nicholas C ^a   Zimonjic, D B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Burkitt's lymphoma; Chromosome alterations; Gene activation; Hepatocellular carcinoma; MYC oncogene; Viral integration

Indexed keywords

ANIMALIA; AVES; ONCOVIRINAE;

BREAST TUMOR; BURKITT LYMPHOMA; CELL CULTURE; CHROMOSOME ABERRATION; GENE AMPLIFICATION; GENE TRANSLOCATION; GENETIC RECOMBINATION; GENETICS; HUMAN; LIVER TUMOR; NEOPLASM; ONCOGENE; REVIEW; TUMOR VIRUS; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

BREAST NEOPLASMS; BURKITT LYMPHOMA; CHROMOSOME ABERRATIONS; GENE AMPLIFICATION; HUMANS; LIVER NEOPLASMS; NEOPLASMS; ONCOGENES; ONCOGENIC VIRUSES; RECOMBINATION, GENETIC; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

EID: 0036545844     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2002.tb00183.x     Document Type: Review

References (55)

1. Bishop J.M., The molecular genetics of cancer, Science, 235: 305-311, 1987
2. Hanahan D., Weinberg, R.A., The hallmarks of cancer, Cell, 100: 57-70, 2000
3. Rabbitts T.H., Chromosomal translocations in human cancer, Nature, 372: 143-149, 1994
4. Mitelman F., Mertens F., Johansson B., A breakpoint map of recurrent chromosomal rearrangements in human neoplasia, Nat. Genet., 15: 417-474, 1997
5. Grisham J.W., Interspecies comparison of liver carcinogenesis implications for cancer risk assessment, Carcinogenesis, 18: 59-81, 1996
6. Hueber A.O., Evan G.I., Traps to catch unwary oncogenes, Trends Genet., 14: 364-367, 1998
7. O'Dwyer M.E., Mauro M.J., and Druker B.J., Recent advancement in the treatment of chronic myelogenous leukemia, Annu. Rev. Med., 53: 369-381, 2002
8. Nowell P., Dalla-Favera R., Finan J., Erikson J., Croce C., Chromosome translocations, immunoglobulin genes, and neoplasia. In Rowley J.D., Ultmann J. E. (eds). Chromosomes and cancer: from molecules to man. New York: Academic Press; 1983, pp. 165-181
9. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.C., Croce C.M., Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells, Proc. Natl. Acad. Sci. U. S. A., 79: 7824-7827, 1982
10. Pelicci P.G., Knowles D.M.D., Magrath I., Dalla-Favera R., Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma, Proc. Natl. Acad. Sci. U. S. A., 83: 2984-2988, 1986
11. Croce C.M., Nowell P.C., Molecular basis of B-cell neoplasia, Blood, 55: 1-7, 1985
12. Croce C.M., Role of chromosome translocation in human neoplasia, Cell, 49: 155-156, 1987
13. Haluska F.G., Tsujimoto Y., Russo G., Isobe M., Croce C.M., Molecular genetics of lymphoid tumorigenesis, Prog. Nucleic Acid Res. Mol. Biol., 36: 269-280, 1989
14. Showe L.C., Ballantine M., Nishikura K., Erikson J., Kaji H., Croce C.M., Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region, Mol. Cell. Biol., 5: 501-509, 1985
15. Zimonjic D.B., Keck-Waggoner C.L., Popescu N. C., Novel genomic imbalances and chromosome translocations involving c-myc gene in Burkitt's lymphoma, Leukemia, 15: 1582-1588, 2001
16. Gurtsevitch V.E., O'Conor G.T., Lenoir G.M., Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice, Int. J. Cancer., 41: 87-95, 1988
17. Forozan F., Mahlamaki E. H., Monni O., Chen Y., Veldman R., Jiang Y., Gooden G. C., Ethier S. P., Kallioniemi A., Kallioniemi O.P., Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data, Cancer Res., 60: 4519-4525, 2000
18. Tirkkonen M.T.M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O.P., Molecular cytogenetics of primary breast cancer by CGH, Genes Chromosomes Cancer, 21: 177-184, 1998
19. Jain A. N., Chin K., Borresen-Dale A-L., Erikstein B.K., Lonning P.E., Kaaresen R., Gray J.W., Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival, Proc. Natl. Acad. Sci. U. S. A., 98: 7952-7957, 2001
20. Alitalo K., Schwab M., Oncogene amplification in tumor cells. Adv. Cancer Res., 47: 235-281, 1986
21. Schimke R.T., Gene amplification in cultured cells. J. Biol. Chem., 63: 5989-5992, 1988
22. Pardue M.L., Dynamic instability of chromosomes and genomes, Cell, 66: 427-431, 1991
23. Kraus M.H., Popescu N.C., Amsbaugh S.C., King C.R., Overexpression of the Egf receptor-related proto-oncogene Erbb-2 in human mammary tumor cell lines by different molecular mechanisms, EMBO J., 6: 605-610, 1987
24. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, 235: 177-182, 1987
25. Pegram M.D., Lipton A., Hayes D.F., Weber B. L., Baselga J.M., Tripathy D., Baly D., Baughman S.A., Twaddell T., Glaspy J.A., Slamon D.J., Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185 HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment, J. Clin. Oncol., 16: 2659-2671, 1998
26. Zimonjic D.B., Keck-Waggoner C.L., Yuan B.Z., Kraus M.H., Popescu N.C., Profile of genetic alterations and tumorigenicity of human breast cancer cells, Int. J. Oncol., 16: 221-230, 2000
27. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R. A., Creation of human tumor cells with defined genetic elements, Nature, 400: 464-468, 1999
28. Zimonjic D.B., Brooks M.W., Popescu N.C., Weinberg R.A., Hahn W.C., Derivation of human tumor cells in vitro without widespread genomic instability, Cancer Res., 61: 8838-8844, 2001
29. Elenbaas B., Spirio L., Koerner F., Fleming M. D., Zimonjic D.B., Donaher J. L., Popescu N. C., Hahn, W. C., Weinberg R.A., Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells, Genes Dev., 15: 50-65, 2001
30. Lundin C., Mertens F., Cytogenetics of benign breast lesions, Breast Cancer Res. Treat., 51: 1-15, 1998
31. Varmus H., Retroviruses, Science, 240: 1427-1435, 1988
32. Peters G., Oncogenes at viral integration sites, Cell Growth Diff., 1: 503-510, 1990
33. Popescu N.C., Chromosome fragility and instability in human cancer, Crit. Rev. Oncog., 5: 121-140, 1994
34. Weinberg R.A., Integrated genomes of animal viruses, Ann. Rev. Biochem., 49: 197-226, 1980
35. Croce C.M., Integration of oncogenic viruses in mammalian cells, Int. Rev. Cytol., 71: 1-17, 1981
36. Popescu N.C., DiPaolo J.A., Amsbaugh S.C., Integration sites of human papilloma-virus 18 DNA sequences on HeLa cell chromosomes, Cytogenet. Cell Genet., 44: 58-62, 1987
37. Popescu N.C., Zimonjic D.B., DiPaolo J.A., Viral integration, fragile sites and protooncogenes in human neoplasia, Hum. Genet., 84: 383-386, 1989
38. Zimonjic D.B., Druck T., Ohta M., Kastury K., Croce C.M., Popescu N.C., Huebner K., Positions of chromosome 3p14. 2 fragile sites (FRA3B) within the FHIT gene, Cancer Res., 57: 1166-1170, 1997
39. Lazo P., DiPaolo J.A., Popescu N.C., Amplification of the integrated viral transforming genes of human papillomavirus 18 and 5′ flanking cellular sequence located near the myc proto-oncogene in HeLa cells, Cancer Res., 49: 4305-4310, 1989
40. Wilke C.M., Hall B.K., Hoge A., Paradee W., Smith D.I., Glover, T.W., FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites, Hum. Mol. Genet., 5: 187-195, 1996
41. Thorland E.C., Myers S.L., Persing D.H., Sarkar G., McGovern R.M., Gostout, B.S., Smith, D.I., Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites, Cancer Res., 60: 5916-5921, 2000
42. Popescu N.C., DiPaolo J.A., Cytogenetics of cervical neoplasia, Cancer Genet. Cytogenet., 60: 214-215, 1992
43. Riou G., Le M.C., Favre M., Jeannel D., Bowrhis J., Orth G., Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancer, J. Natl. Canc. Inst., 84: 1525-1526, 1992
44. Kotin R.M., Menninger J.C., Ward D.C., Berns K.I., Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter, Genomics, 10: 831-834, 1991
45. Samulski R.J., Zhu X., Xiao X., Brook J.D., Housman D.E., Epstein N., Hunter L.A., Targeted integration of adeno-associated virus (AAV) into human chromosome 19, EMBO J., 10: 3941-3950, 1991
46. Rivadeneira E.D., Popescu N.C., Zimonjic D.B., Cheng G.S., Nelson P.J., Ross M.D., DiPaolo J. A., Klotman M.E., Sites of recombinant adeno-associated virus integration, Int. J. Oncol., 12: 805-810, 1998
47. Moroy T., Marchio A., Etiemble J., Trepo C., Tiollais P., Buendia M.A., Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks, Nature, 324: 276-279, 1986
48. Mizuno Y., Murukami S., Matsushita F., Unoura M., Kobayasi K., Migita S., Hatori N., Ohno S., Chromosomal assignment of woodchuck hepatitis virus (WHV) DNA integration sites in a woodchuck hepatocellular carcinoma-derived cell line (WH257GE10), Int. J. Cancer, 43: 652-657, 1989
49. Zimonjic D.B., Keck C.L., Thorgeirsson S.S., Popescu N.C., Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology, 29: 1208-1214, 1999
50. Murakami H., Sanderson N., Nagy P., Marino P., Merlino G.T., Thorgeirsson S. S., Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and TGF-α in hepatic oncogenesis, Cancer Res., 53: 1719-1723, 1993
51. Santoni-Rugiu E., Nagy P., Jensen M.R., Factor V. M., Thorgeirsson S.S., Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor, Am. J. Pathol., 149: 407-428, 1996
52. Santoni-Rugiu E., Jensen M.R., Thorgeirsson S. S., Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha, Cancer Res., 58: 123-134, 1998
53. Sargent L.M., Zhou X., Keck C.L., Sanderson N. D., Zimonjic D.B., Popescu N.C., Thorgeirsson, S.S., Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-myc and transforming growth factor alpha in the liver, Am. J. Path., 154: 1047-1055, 1999
54. Keck C.L., Zimonjic D.B., Yuan, B.Z., Thorgeirsson S.S., Popescu N.C., Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines, Cancer Genet. Cytogenet., 111: 37-44, 1999
55. Popescu N. C., Zimonjic D.B., Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as targets for therapy, Am. J. Med. Genet., 2002 (In Press)